Mukul Minocha
0009-0002-5945-6312
Amgen (United States)
1 paper found
Refreshing results…
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Missing publications? Search for publications with a matching author name.